Corrigendum to “Antigens activated SOCS3+CD200R+CD4+ T cells are critical to Leishmania pathogenesis and a distinctive target for vaccine development” [Vaccine 62 (2025) 127501] (Vaccine (2025) 62, (S0264410X25007984), (10.1016/j.vaccine.2025.127501))

Abstract

The authors regret the error in the acknowledgements in the published article (DOI: https://doi.org/10.1016/j.vaccine.2025.127501). The original text: This work is an output of a project funded to RKS by the Indian Council of Medical Research, New Delhi (No. VIR/12/2022/ECD-1). AS and BM are thankful to UP-CST, Lucknow, and DBT, New Delhi, respectively for their research fellowships. RKS also acknowledges the support received under the Institute of Eminence (IoE 6031), Central Government of India, and Uttar Pradesh council of science and technology (UP-CST/D-2245) for financial assistance. The corrected version: This work is an output of a project funded to RKS by the Indian Council of Medical Research, New Delhi (No. VIR/12/2022/ECD-1). AS and BM are thankful to UP-CST, Lucknow, and DBT, New Delhi, respectively for their research fellowships. RKS also acknowledges the support received under the Institute of Eminence (IoE 6031), Central Government of India, and Uttar Pradesh council of science and technology (UP-CST/D-2245) for financial assistance. PD, the recipient of ICMR-Emeritus Scientist, acknowledges the support of ICMR, New Delhi. This amendment ensures proper acknowledgement of contributions. We sincerely apologize for any inconvenience caused and thank the editors for their understanding. © 2025 Elsevier Ltd